Courses including Sovaldi (Sofosbuvir) indicate greater advantages over other regimens for Hepatitis C Virus Genotype-3.

In the past, treatment therapies for Hep C were quite demanding and not always well-tolerated: they often included multiple separate medicines and complicated dosing, and were frequently causing reactions. Since those times everything has changed dramatically. Gastroenterologists prescribe Sofosbuvir and Daclatasvir and Ribavirin to 60 percent of Genotype-3 patients who undergo treatment. This information is provided by findings from Decision Resources Group.

Decision Resources Group reports that interviewed gastroenterologists in the United States and Europe come to conclusion that the percentage of Hepatitis C virus (HCV) genotype-3 infected patients who suffer from cirrhosis of the liver reach a stable virologic response (SVR). This is one of the aspects that most have impact on their prescribing approaches. Clinical data and surviwed experts point out that Interferon-free courses including Sovaldi (Sofosbuvir) and NS5A inhibitor Daclatasvir present easement and potency advantages over now available treatment courses for HCV genotype-3 infections. It is clear that competition remains.

Pangenotypic interferon- and Ribavirin-free combination of Sovaldi states the fact that up to 100 percent of genotype-3 infected individuals reached SVR4. These speaking results are confirmed, including assessment of a co-formulated Sovaldi and GS-5816 one-pill, once-daily taken course. Thus, this combination provides a highly potent, secure, pangenotypic, and easy to use single-tablet treatment for HCV infections. If we say otherwise, this is one pill that rules them all, the pill that prevails in this sphere.

Evaluated administration of Sovaldi and Daclatasvir combination: gastroenterologists expressed that they would prescribe Sofosbuvir and Daclatasvir plus Ribavirin to 60 percent of their HCV genotype-3 patients.

Summing up, we can say that Sovaldi (Sofosbuvir) is a progressive medicine that directly targets the Hep C virus and kills it. If you are a patient, do not waste your time, use this drug on your way to quick recovery!

www.hcvhelp.net